ARAMIS Publications ARAMIS Primary AnalysisDarolutamide in Nonmetastatic, Castration-Resistant Prostate CancerARAMIS Final AnalysisEfficacy and Safety of Darolutamide in Patients with Nonmetastatic Castration-resistant Prostate Cancer Stratified by...ARAMIS PSADT Subgroup Analysis Efficacy and Safety of Darolutamide in Patients with Nonmetastatic Castration-resistant Prostate Cancer Stratified by...ARAMIS Comorbidities and Medication Post-Hoc AnalysisEfficacy and safety outcomes of darolutamide in patients with non-metastatic castration-resistant prostate cancer wit...ARAMIS Comorbidities and Medication Post-Hoc AnalysisEfficacy and safety outcomes of darolutamide in patients with non-metastatic castration-resistant prostate cancer wit...ARAMIS Statin Use and Oncologic Outcomes Secondary AnalysisStatin use and oncological outcomes in a propensity-matched cohort of nonmetastatic castration resistant prostate can...ARAMIS Extended Safety and TolerabilityExtended Safety and Tolerability of Darolutamide for Nonmetastatic Castration-Resistant Prostate Cancer and Adverse E...
